APEX HealthCare ETF
APXH
APXH was delisted on the 24th of January, 2023.
5 hedge funds and large institutions have $5.98M invested in APEX HealthCare ETF in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
25% more funds holding
Funds holding: 4 → 5 (+1)
8% more capital invested
Capital invested by funds: $5.54M → $5.98M (+$438K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
Foundations Investment Advisors
Phoenix,
Arizona
|
+$600K |
| 2 |
Jane Street
New York
|
+$295K |
| 3 |
ACM
Anfield Capital Management
Irvine,
California
|
+$14.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$10.5K |
APXH Hedge Fund Activity: Q2 2022 in Review
5 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in APEX HealthCare ETF (APXH) for Q2 2022, worth a combined $5.98M — up 7.9% from $5.54M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new APXH positions and 0 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Foundations Investment Advisors, adding an estimated $600K. The largest seller was JP Morgan Chase, cutting an estimated $10.5K.
- 5 institutional investors held APEX HealthCare ETF (APXH) as of Q2 2022, up from 4 in Q1 2022.
- Funds reported $5.98M of APEX HealthCare ETF stock for Q2 2022, up 7.9% quarter-over-quarter.
- 1 fund opened new APEX HealthCare ETF positions in Q2 2022 and 0 closed out, a net change of +1 holder.
- The largest APEX HealthCare ETF buyer in Q2 2022 was Foundations Investment Advisors, an estimated $600K added.
- The largest APEX HealthCare ETF seller in Q2 2022 was JP Morgan Chase, an estimated $10.5K sold.
Based on aggregated 13F filings for Q2 2022.